We found that, of the inhibitors tested, only Salubrinal reduced PD-L1 upregulation on MDS cells (Figures 2F, G) suggesting that the PERK pathway, but not IRE1α, is involved in PD-L1 upregulation on MDS cells. This evidence concerns the gene EIF2AK3 and myelodysplastic syndrome.